Answers are grounded in this paper and cite their sources.
Despite significant therapeutic progress, gastric cancer remains among the deadliest forms of cancer encountered in clinical practice, and this remains true even in the context of declining incidence. Outcomes in advanced disease remain poor and therapy is rarely curative in this setting. Different therapies have developed in the hopes of altering nearly uniformly poor outcomes.
No takes yet. Share an insight, caveat, or question.
Herrera et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: